Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, and Samuel Wilkinson, MD, associate professor of
BELLAIRE, Texas, Aug. 11, 2020 /PRNewswire/ — Ketamine, which was originally developed as an anesthetic, has emerged over the last two decades
A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms
In March 2019, intranasal esketamine—a form of ketamine marketed as SPRAVATO™ CIII Nasal Spray*—was approved by the U.S. Food and
A single dose of ketamine may be able to curb harmful drinking behavior by “rewriting drinking memories,” according to a
When I entered the ketamine clinic for the first time, I started crying almost immediately. This was for two reasons:
With a special interest in treatment-resistant disorders, Dr. Sandhya Prashad works closely with each patient, taking the time to understand their overall health and well-being so she can develop a truly customized treatment plan.
What Is The Difference Between Bipolar 1 & 2?
Do Depression Rates Rise During The Holidays?
© 2025 Sandhya Prashad, MD. All rights reserved.